+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurotrophic Keratitis Market Outlook 2023-2036

  • PDF Icon

    Report

  • 155 Pages
  • January 2024
  • Region: Global
  • Research Nester Pvt. Ltd
  • ID: 5955158
Description Jump to:
The global neurotrophic keratitis market is anticipated to grow at a CAGR of 17.07% over the forecast period, i.e., 2024 - 2036. The increasing prevalence and incidences of neurotrophic keratitis, upsurge the demand for novel therapies & treatment, advancement in neurotrophic keratitis treatment are the few factors that are driving the market growth. The market is estimated to garner a revenue of USD 1.45 billion by the end of 2036, up from a revenue of USD 192.54 million in the year 2023.

The global neurotrophic keratitis market is segmented by treatment type, application, and by region. On the basis of treatment type, the market is segmented into surgical intervention and drugs. By the end of 2036, the drugs segment is anticipated to garner the largest revenue of around USD 1.06 billion, up from a revenue of nearly USD 138.69 million in the year 2023. The market for neurotrophic keratitis is defined by a variety of medications created to handle the particular difficulties this illness presents. Bacterial invasion is more likely in situations where the cornea is damaged, such as chronic epithelial abnormalities. Antibiotics aid in the management and prevention of bacterial infections that may worsen the illness which is responsible for the growth of this segment.

On the basis of region, the global neurotrophic keratitis market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. By the end of 2036, it is predicted that the North American market will have the highest revenue of around USD 458.34 million out of all the markets in the other areas. Moreover, in the year 2023, the regional market generated a revenue of nearly USD 60.07 million. To improve therapeutic efficacy and diagnostic accuracy, medical practitioners in the area are taking a multidisciplinary approach, merging their experience in neurology, infectious diseases, and ophthalmology. This cooperative approach facilitates the development of focused treatment methods and adds to a more thorough understanding of neurotrophic keratitis.

Some of the prominent industry leaders in the global neurotrophic keratitis market that are included in our report are Oyster Point Pharma, Inc., Neuroptica, Inc., Recordati Rare Diseases, KALA BIO, ReGenTree, LLC, BRIM Biotechnology, Inc., Bausch + Lomb Incorporated, Oculis, HLB Therapeutics

Table of Contents

1. An Introduction to the Research Study
1.1. Preface
1.2. Market Taxonomy
1.3. Definition of the Market and the Segments
1.4. Acronyms and Assumptions
2. The Research Procedure
2.1. Sources of Data
2.2. Secondary
2.3. Primary
2.3.1. Manufacturer Front
2.3.2. Supplier/Distributor Front
2.3.3. End-User Front
2.4. Calculation and Derivation of Market Size
2.4.1. Top-Down Approach
2.4.2. Bottom-up Approach
3. Recommendation by Analyst for C-level Executives4. An Abstract of the Report
5. Evaluation of Market Fluctuations and Outlook
5.1. Market Growth Drivers
5.2. Market Growth Deflation
5.3. Market Trends
5.3.1. Manufacturer Based
5.3.2. End-User Based
6. Fundamental Market Prospects
6.1. Strategic Competitive Opportunities
6.2. Geographic Opportunities
6.3. Application Centric Opportunities
7. Regulatory & Standards Landscape8. Economic Outlook: Japan9. Recent Trends/ Developments in Global Neurotrophic Keratitis Market10. Technology Transition & Adoption Analysis11. Industry Value Chain Analysis12. Industry Risk Analysis13. Pipeline Analysis14. Market Unmet Needs Analysis15. Industry Growth Outlook
16. Global Neurotrophic Keratitis Market Outlook
16.1. Market Overview
16.2. Market Value (USD Million) Current and Future Projections, 2023-2036
16.3. Market Increment $ Opportunity Assessment, 2023-2036
16.4. Year-on-Year (YoY) Growth Trend Analysis
Global Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
16.5. By Treatment Type
16.5.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
16.5.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
16.5.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
16.5.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Global Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
16.6. By Application
16.6.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
16.6.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
16.6.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
Global Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
16.7. By Geography
16.7.1. North America Market Value (USD Million) Current and Future Projections, 2023-2036
16.7.2. Europe Market Value (USD Million) Current and Future Projections, 2023-2036
16.7.3. Asia Pacific Excluding Japan (APEJ) Market Value (USD Million) Current and Future Projections, 2023-2036
16.7.4. Japan Market Value (USD Million) Current and Future Projections, 2023-2036
16.7.5. Latin America Market Value (USD Million) Current and Future Projections, 2023-2036
16.7.6. Middle East & Africa Market Value (USD Million) Current and Future Projections, 2023-2036
17. Cross Analysis of Treatment Type w.r.to. Application (USD Million), 2023-2036
18. North America Neurotrophic Keratitis Market Outlook
18.1. Detailed Overview
18.2. Market Value (USD Million) Current and Future Projections, 2023-2036
North America Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
18.3. By Treatment Type
18.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
18.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
18.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
18.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
North America Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
18.4. By Application
18.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
18.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
18.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
North America Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
18.5. By Country
18.5.1. US Market Value (USD Million) Current and Future Projections, 2023-2036
18.5.2. Canada Market Value (USD Million) Current and Future Projections, 2023-2036
19. Europe Neurotrophic Keratitis Market Outlook
19.1. Detailed Overview
19.2. Market Value (USD Million) Current and Future Projections, 2023-2036
Europe Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
19.3. By Treatment Type
19.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
19.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
19.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
19.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Europe Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
19.4. By Application
19.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
19.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
19.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
Europe Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
19.5. By Country
19.5.1. Germany Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.2. France Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.3. England Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.4. Italy Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.5. Spain Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.6. Netherlands Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.7. Russia Market Value (USD Million) Current and Future Projections, 2023-2036
19.5.8. Rest of Europe Market Value (USD Million) Current and Future Projections, 2023-2036
20. Asia Pacific Excluding Japan (APEJ) Neurotrophic Keratitis Market Outlook
20.1. Detailed Overview
20.2. Market Value (USD Million) Current and Future Projections, 2023-2036
Asia Pacific Excluding Japan (APEJ) Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
20.3. By Treatment Type
20.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
20.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
20.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
20.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Asia Pacific Excluding Japan (APEJ) Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
20.4. By Application
20.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
20.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
20.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
Asia Pacific Excluding Japan (APEJ) Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
20.5. By Country
20.5.1. China Market Value (USD Million) Current and Future Projections, 2023-2036
20.5.2. India Market Value (USD Million) Current and Future Projections, 2023-2036
20.5.3. South Korea Market Value (USD Million) Current and Future Projections, 2023-2036
20.5.4. Australia Market Value (USD Million) Current and Future Projections, 2023-2036
20.5.5. Singapore Market Value (USD Million) Current and Future Projections, 2023-2036
20.5.6. Rest of APEJ Market Value (USD Million) Current and Future Projections, 2023-2036
21. Japan Neurotrophic Keratitis Market Outlook
21.1. Detailed Overview
21.2. Market Value (USD Million) Current and Future Projections, 2023-2036
Japan Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
21.3. By Treatment Type
21.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
21.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
21.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
21.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Japan Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
21.4. By Application
21.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
21.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
21.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
22. Latin America Neurotrophic Keratitis Market Outlook
22.1. Detailed Overview
22.2. Market Value (USD Million) Current and Future Projections, 2023-2036
Latin America Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
22.3. By Treatment Type
22.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
22.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
22.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
22.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Latin America Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
22.4. By Application
22.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
22.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
22.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
Latin America Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
22.5. By Country
22.5.1. Brazil Market Value (USD Million) Current and Future Projections, 2023-2036
22.5.2. Mexico Market Value (USD Million) Current and Future Projections, 2023-2036
22.5.3. Argentina Market Value (USD Million) Current and Future Projections, 2023-2036
22.5.4. Rest of Latin America Market Value (USD Million) Current and Future Projections, 2023-2036
23. Middle East & Africa Neurotrophic Keratitis Market Outlook
23.1. Detailed Overview
23.2. Market Value (USD Million) Current and Future Projections, 2023-2036
Middle East & Africa Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
23.3. By Treatment Type
23.3.1. Segmentation by Drugs Market Value USD Million) Current and Future Projections, 2023-2036
23.3.1.1. Artificial Tears Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.1.2. Recombinant Human Nerve Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.1.3. Growth Factors Eye Drops Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.1.4. Antibiotics Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.1.5. Bandage Contact Lens Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.1.6. Others Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.2. Segmentation by Surgical Intervention Market Value USD Million) Current and Future Projections, 2023-2036
23.3.2.1. Tarsal Plate Suture Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.2.2. Amniotic Membrane Transplant Market Value (USD Million) Current and Future Projections, 2023-2036
23.3.2.3. Others Market Value (USD Million) Current and Future Projections, 2023-2036
Middle East & Africa Neurotrophic Keratitis Market Outlook & Projections, Opportunity Assessment by Segment, 2023-2036
23.4. By Application
23.4.1. Stage I Market Value (USD Million) Current and Future Projections, 2023-2036
23.4.2. Stage II Market Value (USD Million) Current and Future Projections, 2023-2036
23.4.3. Stage III Market Value (USD Million) Current and Future Projections, 2023-2036
Middle East & Africa Neurotrophic Keratitis Market Segmentation Analysis (2023-2036)
23.5. By Country
23.5.1. Combined Gulf Countries Market Value (USD Million) Current and Future Projections, 2023-2036
23.5.2. Israel Market Value (USD Million) Current and Future Projections, 2023-2036
23.5.3. South Africa Market Value (USD Million) Current and Future Projections, 2023-2036
23.5.4. Rest of MEA Market Value (USD Million) Current and Future Projections, 2023-2036
24. Competitive Model: A Detailed Inside View for Investors
24.1. Company Market Share (2022)
24.2. Business Profile of Key Enterprise
24.2.1. Dompé
24.2.2. Oyster Point Pharma, Inc.
24.2.3. Neuroptica, Inc.
24.2.4. Recordati Rare Diseases
24.2.5. KALA BIO
24.2.6. ReGenTree, LLC
24.2.7. BRIM Biotechnology, Inc.
24.2.8. Bausch + Lomb Incorporated
24.2.9. Oculis
24.2.10. HLB Therapeutics

Companies Mentioned

  • Oyster Point Pharma Inc.
  • Neuroptica Inc.
  • Recordati Rare Diseases
  • KALA BIO
  • ReGenTree LLC
  • BRIM Biotechnology Inc.
  • Bausch + Lomb Incorporated
  • Oculis
  • HLB Therapeutics

Related Topics

Related Reports

Neurotrophic Keratitis Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Neurotrophic Keratitis Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 145 Pages
  • Global
From
Neurotrophic Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Neurotrophic Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 136 Pages
  • Global
From
Neurotrophic Keratitis Treatment Global Market Report 2024 - Product Image

Neurotrophic Keratitis Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Neurotrophic Keratitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Image

Neurotrophic Keratitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • 120 Pages
  • Asia Pacific
From
Fungal Keratitis Treatment Market by Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Fungal Keratitis Treatment Market by Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From

About the Neurotrophic Keratitis Drug Market

Neurotrophic Keratitis (NK) is a rare, degenerative eye disorder that affects the cornea, the clear outer layer of the eye. It is caused by a lack of nerve supply to the cornea, resulting in decreased tear production and corneal thinning. NK is treated with a variety of drugs, including topical corticosteroids, antibiotics, and immunomodulators. These drugs are used to reduce inflammation, improve tear production, and protect the cornea from further damage. Optical Disorders Drugs are a class of drugs used to treat a variety of eye diseases, including NK. These drugs are designed to reduce inflammation, improve tear production, and protect the cornea from further damage. They are typically administered topically, either as eye drops or ointments. Some companies in the Neurotrophic Keratitis Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, and Shire. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.